BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22790942)

  • 21. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
    Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
    Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.
    Pei Y; Hodgins DC; Wu J; Welch SK; Calvert JG; Li G; Du Y; Song C; Yoo D
    Virology; 2009 Jun; 389(1-2):91-9. PubMed ID: 19423145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mutations in the VP2/VP4 cleavage site of Swine vesicular disease virus on RNA encapsidation and viral infectivity.
    Rebel JM; Leendertse CH; Dekker A; Moormann RJ
    Arch Virol; 2003 Sep; 148(9):1747-56. PubMed ID: 14505087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackievirus B3 used as a gene therapy vector to express functional FGF2.
    Kim DS; Kim H; Shim SH; Kim C; Song M; Kim YH; Jung YW; Nam JH
    Gene Ther; 2012 Dec; 19(12):1159-65. PubMed ID: 22170343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.
    Kim DS; Park JH; Kim JY; Kim D; Nam JH
    Virus Genes; 2012 Apr; 44(2):176-82. PubMed ID: 22038539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins.
    Warner SC; Desai P; Person S
    Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A.
    Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC
    Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.
    Weigand K; Knaust A; Schaller H
    J Gen Virol; 2010 Jan; 91(Pt 1):59-67. PubMed ID: 19741067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Destabilization of coxsackievirus b3 genome integrated with enhanced green fluorescent protein gene.
    Tong L; Lin L; Zhao W; Wang B; Wu S; Liu H; Zhong X; Cui Y; Gu H; Zhang F; Zhong Z
    Intervirology; 2011; 54(5):268-75. PubMed ID: 21242657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portal fusion protein constraints on function in DNA packaging of bacteriophage T4.
    Baumann RG; Mullaney J; Black LW
    Mol Microbiol; 2006 Jul; 61(1):16-32. PubMed ID: 16824092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
    Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
    Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
    Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
    Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three capsid amino acids notably influence coxsackie B3 virus stability.
    Carson SD; Tracy S; Kaczmarek ZG; Alhazmi A; Chapman NM
    J Gen Virol; 2016 Jan; 97(1):60-68. PubMed ID: 26489722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective recruitment of Adh genes for distinct enzymatic functions in Petunia hybrida.
    Garabagi F; Duns G; Strommer J
    Plant Mol Biol; 2005 May; 58(2):283-94. PubMed ID: 16027979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3.
    Wang T; Yu B; Lin L; Zhai X; Han Y; Qin Y; Guo Z; Wu S; Zhong X; Wang Y; Tong L; Zhang F; Si X; Zhao W; Zhong Z
    Virology; 2012 Nov; 433(2):513-21. PubMed ID: 23010168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving protein functional diversity in new genes of Drosophila.
    Zhang J; Dean AM; Brunet F; Long M
    Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16246-50. PubMed ID: 15534206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket.
    Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M
    Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.